“There is reason to believe he may have violated” the primary federal conflict-of-interest law by “participating personally and substantially in particular matters affecting companies in which he holds stock,” said a$506,043 and $1.64 million worth of stocks
in companies doing work related to the Trump administration’s pandemic response. Short even declared some of his holdings a potential conflict of interest after joining Pence’s office last year, but he did not sell them after he was denied a capital gains tax break in the event of a sale. Short has claimed he is skirting conflict of interest issues by recusing himself from specific matters that could bolster his investments. Yet CREW wrote Wray that the “breadth of his investment portfolio casts serious doubt as to whether recusal is feasible.”
The White House press office reported earlier this year that Short was expected to attend meetings in March and April regarding the COVID-19 response with representatives from United Health Group, CVS, Johnson & Johnson, Pfizer, Walmart and Disney — all companies in which Short has investments, CREW noted. Photos have shown him attending those meetings, according to CREW.
He and his wife also own stock in 3M, Abbott Laboratories, Gilead Sciences, Procter & Gamble, Medtronic, Bristol Myers Squibb, Thermo Fisher Scientific and Roche, NPR reported.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: bbchealth - 🏆 143. / 63 Read more »